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ABSTRACT

The Impact of Lipid Percentage on Fibrous Cap Stability in Atherosclerotic
Lesions
Anita Lorraine Crompton

Coronary artery disease (CAD) is a common cause of sudden cardiac death.
Much of the disease is not completely understood, which makes treatment
and prevention difficult. Many researchers are using technology, such as
advanced imaging techniques and finite element analysis, to better
understand the disease. While there is much progress being made to look at
the analysis of actual excised diseased arteries, there is still not a
standardized model to predict the future of any one lesion. The purpose of
this study is to explore the possibility of creating a standardized model to
predict the mechanical stability of the fibrous cap due to lipid content in
atherosclerotic lesions.
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INTRODUCTION

Coronary artery disease (CAD) is the leading cause of death in United States.
CAD is simply described as the lack of oxygen transport to the myocardium
due to the inefficiency of the coronary artery to correctly transport blood.
Because the heart is a vital muscle to the transport oxygen, nutrients, and
waste throughout the body, coronary artery disease can often be fatal. Many
efforts have been made to prevent deaths due to this disease; however there
are still much needed improvements on current treatment and preventative
methods. Atherosclerosis can cause CAD when plaque builds up in the
lumen of arteries that provide blood to the heart. Eventually, this buildup can
significantly (or completely) close the lumen and disrupt efficient blood flow. It
can also fissure or rupture, causing the formation of a thrombus that can
eventually get caught elsewhere in the vascular system.

When the heart muscle is not receiving enough blood, angina pectoris can
occur, which causes chest pain, but is not immediately fatal to the myocardial
cells. If the myocardial cells do not receive enough blood for long periods of
time, they can die, causing a myocardial infarction. This is a very serious
complication of CAD as it is often fatal.

In order to prevent myocardial infarctions doctors may choose from either
minimally invasive clinical treatments, such as angioplasty or stents, or more
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invasive open-chest surgery. In severe cases, bypass surgery can be
performed, where the surgeon takes a part of the patient’s saphenous vein
and “re-routes” the bloodstream past the blockage. Although bypass surgery
is usually successful, there may be limitations on the availability of a healthy
saphenous vein due to a limited supply and other possible diseases. While
synthetic grafts are used in some areas of the body, they are not able to be
used for coronary arteries due to their small diameter. If disease behavior
and biomechanics could be better understood, dangerous disease states
could be detected early and accurately. With this knowledge, doctors would
be able to provide safer and more effective treatment.

Although clinical knowledge of atherosclerosis has rapidly increased over the
last couple of decades, it is still very difficult to predict its progression in a
specific patient. Research in vascular physiology and physical and numerical
modeling may one day allow for significantly more effective disease detection
and treatment. This paper discusses the progression of atherosclerosis, the
mechanical properties of the tissues involved, and the vulnerable states of the
disease. A finite element method is then used to test the vulnerability of
different lesion morphologies, followed by a discussion of how the model can
be applied clinically.
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CHAPTER ONE: ATHEROSCLEROSIS PROGRESSION AND
CLASSIFICATION

Atherosclerosis is a disease that affects the tunica intima (the innermost
layer) of arteries. Unfortunately, much about the physiologic initiation and
progression of the disease is still not understood. Many theories have
evolved over time, and today it is agreed upon that inflammation plays a
major role.

NORMAL ARTERY ANATOMY AND PHYSIOLOGY

The cardiovascular system is extremely important to the human body, as the
circulation of blood to every cell in the body is necessary for survival. Since
oxygen can only diffuse freely 200µm, the vascular system must be able to
pump blood to every cubic centimeter of the body. In addition to the large
amount of capillaries necessary to reach every cell, the heart must be efficient
enough to pump blood through the entire arterial system. In order for the
heart to be efficient, is necessary for the vascular system to also deliver
oxygen-rich blood to the myocardial cells.

This system is composed of many arteries and veins that allow blood to flow
between the heart, lungs, and other tissues in the body. Arteries are the
vessels responsible for delivering blood from the heart to all the tissues in the
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body; therefore, normal function is of great importance. Arteries are
composed of three concentric layers, or tunics: the intima, media, and
adventitia. The intima is the innermost layer and makes up the lumen of the
vessel. It contains a monolayer of endothelial cells that continue from the
endocardium of the heart. Because it is in direct contact with flowing blood,
the endothelium provides a low friction interface that discourages platelets
from coagulating. The middle layer, or media, is the thickest layer in these
arteries and contains smooth muscle cells and elastin that control vasodilation
and vasoconstriction. These cells are what give the vessel most of its tensile
strength. The outer layer, called the adventitia, surrounds the vessel and
contains collagen fibers which aid in protection and reinforcement. A normal
artery can be seen in Figure 1.

Figure 1. THE NORMAL ARTERY A healthy artery consists of three tunics: the intima,
media and adventitia. The intima contains the endothelial lining, which has nonthrombogenic properties and is in direct contact with the blood.
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PROGRESSION OF ATHEROSCLEROSIS

The development of a clinically significant atherosclerotic lesion typically
takes decades, and there are many types of lesions and factors involved in
disease progression. Plaque buildup due to atherosclerosis is thought to be
an inflammatory response that builds up smooth muscle cells, calcium, and
other products over time.
The initiation of a lesion is due to the adhesion of mononuclear leukocytes to
the endothelium. The exact reason for this is unknown, but it is believed that
a disruption in the endothelial lining, possibly due to normal blood flow or
infection, may cause this inflammatory response. However, there is also
speculation that the adhesion of leukocytes can happen without endothelial
disruption, so the subject still remains somewhat controversial. After
adhering to the endothelial lining, the leukocytes are drawn into the intima by
chemoattractants. This causes a local inflammatory response, and the
leukocytes become macrophages. The macrophages then engulf lipids and
become foam cells. This phagocytosis can happen when low density
lipoproteins from the blood plasma become oxidized and bind to the
macrophages. An accumulation of these foam cells is typically referred to as
a fatty streak, which is the initial precursor to the progression of advanced
atherosclerosis. Fatty streaks are present in the first decades of life, and
some research even shows that initial fatty streaks can be present upon birth.
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It is possible for a disease state consisting of fatty streaks to completely
reverse, so is not considered clinically dangerous. As the disease
progresses, lipoproteins accumulate beneath the endothelial lining. This may
happen after the lipoproteins are released by necrotic subendothelial foam
cells. The exact reason for the death of foam cells is unknown, but it may be
due to signals that cause the cells to undergo apoptosis. An accumulation of
lipoproteins underneath the endothelial lining is termed atheroma.

As time and accumulation of foam cells progresses, growth factors are
released that encourage the growth of smooth muscle cells and fibrous
tissue. The smooth muscle cells produce an extracellular matrix which
contributes to the fibrous properties of a more advanced lesion. Collagen and
smooth muscle cells grow around the atheromatous core to help prevent its
clotting factors from coming into contact with the bloodstream, and a fibrous
cap develops. This is often thought to help stabilize the lesion, but is also a
controversial issue. A lesions containing an atheromatous core surrounded
by a fibrous cap is a fibroatheroma. A fibroatheroma may have multiple lipid
pools surrounded by fibrous tissue. The thickness and mechanical properties
of the fibrous tissue varies greatly between lesions and is largely dependent
on biological factors.

Some lesions develop calcific regions, which can be located anywhere within
the lesion, but are usually closer to the media. The exact mechanism of this
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calcification is unknown, but some researchers hypothesize that it may be
due to the mineralization of vesicles from dead cells. Another speculation is
that smooth muscle cells produce proteins that promote bone formation and
mineralization.

7

Figure 2. ARTERY WITH CALCIFIC REGIONS MRI and histological image from a study
44
done by Tang et al. (a) MR image (b) histological image

Figure 2 shows a histological image and its corresponding MRI of an
atherosclerotic lesion containing an atheroma, fibrous cap, calcium. The
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morphology of each lesion varies greatly between each person, and can even
vary between arteries in the same person. Efforts are currently being made
to discuss methods of classifying these morphologies so that clinicians can
better choose the proper treatment for their patients.

CLINICAL IMPLICATIONS

An atherosclerotic lesion becomes clinically relevant when it causes stenosis
of the lumen, or becomes likely to rupture or cause a thrombus. A severely
stenosed lumen can be debilitating, especially when it is in the coronary
arteries and causes angina pectoris. If the fibrous cap ruptures, a thrombus
will most likely form when blood is exposed to clotting factors below the
endothelial surface. The thrombus may occlude the artery at the lesion site,
or break loose, get caught and inhibit blood flow elsewhere.

There are many possible causes for plaque rupture. One possible cause is
stress on the intimal lining due to normal physiologic stresses, such as blood
flow. The constant pulsatile flow of blood causes fatigue and weakens the
fibrous cap over time. High blood pressure can impose a greater than normal
stress, and thus is a risk factor for plaque disruption. Hemodynamic (shear)
stresses usually do not facilitate plaque rupture since the mechanical stresses
due to the pulsatile flow of blood exceed any stresses related to the
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circulation of blood. Other triggers may be internal; for instance, newly
formed thin walled blood vessels inside the plaque may bleed into the lesion
and cause internal pressures on the fibrous cap.

Lesions which are prone to rupture include those with large lipid pools, thin
fibrous caps, and caps with low collagen content. Large atheromatous cores
are typically classified as those in which the lipid pool occupies 40% or more
of the plaque. Since the lipid core is softer than the fibrous cap, it does not
absorb nearly as much stress. This extra stress on the fibrous cap can cause
it to rupture. The size of the fibrous cap varies greatly between lesions, as
does the thickness required to consider a cap stable. For instance, the range
of cap thickness of stable coronary lesions can range from 65 µm to 250 µm,
depending on the mechanical properties of the fibrous tissue of the cap.
Caps that have higher collagen content and more smooth muscle cells, which
make collagen, are more stable because they can handle a greater
mechanical load without rupturing. Plaques that contain a considerable
number of macrophages tend to be weaker due to the capability of the
macrophages to degrade the extracellular matrix. Plaques are thinner and
have weaker mechanical properties at the shoulders of the lesion, so this is a
common site for disruption of the fibrous cap.

Just as many factors can cause plaque vulnerability, many factors are
involved with plaque stability. Stable plaques include those with thicker

10

fibrous caps and high collagen content, and also plaques that greatly stenose
the arterial lumen. It is important to note, however, that lesions which cause a
great degree of stenosis may still be clinically relevant due to their ability to
cause ischemia. They are also exposed to shear stresses far greater than
normal, so hemodynamic flow may cause cap rupture in this case. Plaques
which contain calcium deposits are sometimes thought to be more stable
because they take some of the mechanical load off of the fibrous cap. This,
however, is still up for debate and is not yet proven.

CLASSIFICATION SYSTEMS

Many researchers have attempted to provide a classification system to draw
correlations between plaque stability, cellular content and progression of the
disease. The American Heart Association, through the work of H. C. Stary et
al., developed a classification system in 1995 based on disease progression.
This system divided the disease into six different states, the first three of
which were considered early and stable, and the last three of which were
considered advanced and vulnerable. The first three types, named type I,
type II, and type III, described the disease progression from initiation, to fatty
streaks and dots, and finally to the accumulation of a lipid core. The types
beyond type III are considered advanced lesions and clinically relevant.
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Once the lesion has a considerable lipid core, it is considered a type IV
lesion, which is the first of the advanced lesions. This legion contains a large
accumulation of foam cells, which make up an eccentric lipid core visible to
the naked eye, but does not normally narrow the lumen. It also has not yet
developed a significant increase in smooth muscle cells or fibrous tissue. As
far as mechanical stability, this type of lesion may be prone to fissure
because of the lack of a strong fibrous cap.

A lesion is considered to be type V if it has a decent amount of other
materials, such as fibrous tissue or calcium, but it may or may not have a lipid
core. A fibroatheroma (lipid core surrounded by a fibrous cap) is a type Va
lesion. This also includes multilayered fibroatheromas (multiple atheromas
layered in the intima and fibrous caps in between them). If the lesion contains
calcific regions, it is termed type Vb. A lesion with minimal lipid content that
lacks a lipid core is a type Vc lesion. It could be made up of either fibrous
tissue or mineralized deposits.

Lesions of types IV and V become type VI lesions when they develop
disruptions such as a fissure, rupture, hematoma, or formation of a thrombus.
Stary et al. refer to this type as a complicated lesion. A disruption of the
surface makes the lesion type Via; a hematoma or hemorrhage, type VIb; and
formation of a thrombus, type VIc. Any lesion can also contain more than one
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of these features, making it a type VIab, VIac, VIbc, or VIabc. The plaque
ruptures of type VI lesions are what cause clinical events.

Figure 3. PLAQUE CLASSIFICATIONS Cross sections of each type of lesion as
43
described by Stary et al.
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Cross sections of each type of lesion described by Stary et al. are shown in
Figure 3. This classification system has been used to classify atherosclerosis
in many studies since its creation in 1995; however, recent developments in
the understanding of the disease have led some researchers to develop
different techniques for determining the clinical relevance of various disease
states.

In 2003, the American Heart Association published an article by Morteza
Naghavi et al. that focused on plaque vulnerability rather that disease
progression. This system makes some sense since it is the vulnerable
lesions that are the most clinically relevant. Their system uses nomenclature
to describe lesions, rather than lumping lesions into different classifications.
A combination of major and minor risk factors is used to describe the risk of
plaque rupture. These risk factors be due to the physical properties of the
lesion, and can also be due to the physiologic state of the patient (such as
those prone to platelet coagulation and hypertension). Figure 4 is used by
the group to outline different types of vulnerable plaque based on the physical
properties of the lesion. It is the intent of this system to treat each physical
property of the lesion as a separate risk factor that may or may not develop in
a specific order. This way, each lesion can be defined according to its exact
physical elements, without implying how long the lesion has been present.
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Figure 4. TYPES OF VULNERABLE PLAQUE Examples of different types of
34
vulnerable plaque as described by Naghavi et al.

Naghavi et al. also aimed to unify the somewhat subjective research
language. They thought that the adjectives used by researches to describe
histology and plaque vulnerability could have different meanings, depending
on who used them. Their proposed definitions are as follows:
Culprit plaque: A plaque that has caused a coronary occlusion and
death.
Vulnerable plaque: A plaque including risk factors that make it
succeptible to becoming a “culprit” plaque.
Table 1 by Naghavi et al. describes many previously used terms to describe
the sort of plaque disruption that caused a culprit plaque.
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Table 1: Terminology for Culprit Plaques

Table 2. Different terminology used to describe culprit plaques, as researched by
34
Naghavi et al.

After describing the difference between culprit and vulnerable plaque,
Naghavi et al. outlined some risk factors for vulnerable plaque. The major
risk factors are shown in Table 2. They include active inflammation, a thin
fibrous cap with a large lipid core, surface disruption with superficial platelet
aggregation, fissured or injured plaque, and severe stenosis. A thin fibrous
cap in this classification system has a width of 100 µm or less, and a large
lipid core is one that makes up 40% or more of the lesion volume. They
consider severe stenosis as a major risk factor because shear stress on the
plaque surface increases with the narrowing of the lumen.
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Table 2: Risk Factors of Vulnerable Plaque

Major

Minor

Active Inflammation

Superficial calcified modules
(close to fibrous cap)

Thin fibrous cap (<100 µm) with large lipid
core (>40% of plaque volume)

Yellow color seen during
angioplasty

Surface disruption and superficial platelet
aggregation

Intraplaque hemorrhage

Fissured or injured plaque

Endothelial dysfunction

Severe stenosis

Positive (toward tunica media)
remodeling

Table 3. Major and minor risk factors for vulnerable plaque determined by Naghavi et
al.

The minor risk factors outlined in the group’s work are also outlined in Table
2. They include: superficial calcified nondules, yellow color on angioscopy,
intraplaque hemorrhage, endothelial dysfunction, and positive remodeling. If
calcium nodules are located near the cap instead of on the medial side of the
lesion, they can protrude through the cap, causing rupture. A yellow color on
angioscopy can denote a large lipid core and thin fibrous cap, in which case it
could be a major risk factor. An intraplaque hemorrhage can disrupt the
plaque stability. Endothelial dysfunction is considered a minor risk factor due
to the possibility of inflammation and the observed correlation to coronary
disease and stroke. Remodeling of the intima that preserves the lumen and
instead expands the artery can be seen as a minor risk factor due to the
correlation of clinical events with non stenosed arteries. These minor risk
17

factors, while not a direct precursor to coronary events, have been observed
in arteries undergoing coronary events, so they are worth noting in the
prediction of plaque vulnerability.

This method of describing atherosclerosis provides detailed communication
between researchers. It seems that in recent years, scholars in the field have
started to shy away from the popular Stary et al. “type” classification system,
and have instead defined lesions based on their individual properties. For the
purposes of this paper, individual traits will be used to describe various
lesions.
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CHAPTER TWO: USING TECHNOLOGY TO DISCOVER PLAQUE
VULNERABILITY

The use of technology to diagnose high risk states of atherosclerosis is a
growing field of research. Currently, angiography and the diagnosis of patient
risk factors are the only methods of predicting potentially fatal clinical events.
Angiography comes with a great possibility of risk to the patient because of its
invasive nature. One major drawback is that it only allows the physician to
observe the endothelial lining of the lesion, which means he/she can not
determine much other than the degree of stenosis.

The identification of patient risk factors allows for correlation to plaque
vulnerability, and may aide in the prediction of a clinical event, but it does not
perfectly predict that possibility. Many researchers are attempting to develop
non-invasive techniques for the diagnosis of vulnerable disease states by
finding correlations between medical images and mechanical stability.
Images can be combined with previous knowledge about physical properties
of lesions and vulnerability to predict more accurately the behavior of a
specific lesion.

Medical images, such as MRIs, provide entire cross sections of arteries with
lesions. They show great promise in distinguishing between the different
materials of the plaque, and are already a widely used diagnostic tool. Not
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only is it a great non-invasive technique for looking at tissues inside the body,
but it can also pick up on materials not visible to the naked eye. The media
used to scan can vary depending on the image type. For instance, ultrasound
and MR techniques use harmless sound and magnetic waves to determine
the shape of the tissue of interest, while CT and fluoroscopy techniques use
radiation. The type of imaging used depends on the make-up and density of
the tissue of interest. In the vascular field, a few techniques are currently
being researched to determine lesion composition. These include ultrasound
(US), magnetic resonance (MR) imaging, and optical coherence tomography
(OCT).

Research is being done to correctly correlate images with known mechanical
properties for use in finite element analysis. This may sound like
straightforward research in theory, but the numerous combinations of lesion
materials and mechanical properties makes data unification pretty difficult.
The aim of this chapter is to explore current research in each of these areas,
and consider how they are capable of fitting together.

MECHANICAL ANALYSIS USING IVUS

Intravascular ultrasound (IVUS) elastography can be used as a functional
imaging technique, because it allows for both visualization of lesion
components and compressive radial strain. An example of an IVUS
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elastogram is shown by Figure 5, which was produced in a study done by
Radj A. Baldewsing et al. The figure shows the elastograms with the
corresponding histological images of the excised arteries used. They
compared this elastogram with a finite element analysis done on a geometry
obtained from the ultrasound image.

Figure 5. IMAGES OF IVUS ELASTOGRAMS Images of an artery cross section from
the work of Baldewsing et al. (a) IVUS image. (b) IVUS elastogram. (c)-(e) histological
3
images.

Their results are shown in Figure 6. While the IVUS elastogram is a good
indicator of arterial strain, the group argues that a finite element analysis may
be needed to verify that certain areas of strain are in fact due to lesion
components. They say that the strain in IVUS elastography may be altered
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due to artery material properties, geometry, and placement of the IVUS
catheter. The lesion and arterial components were given linear elastic and
incompressible material properties. The justification for this is that the range
of physiologic deformations is small enough for the system to be locally linear
elastic.

Figure 6. IVUS STRESS/STRAIN ANALYSIS Results of the stress/strain analysis by
Baldewsing et al. (a) optical image (b) IVUS elastogram (c) FEA analysis (d) diagram of
Young's modulus used in the
3
FEA.

MECHANICAL ANALYSIS USING MR IMAGING

Magnetic resonance imaging is perfect for looking at soft tissues in the body.
It can have great resolution, and can be manipulated to further single out
certain tissue characteristics, such as fat. MR imaging has been used in
research to help determine tissue composition of lesions. Many studies have
used real MR images to determine lesion geometries for finite element
analysis.
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Z. Yong Li et al. used this type of imaging for their finite element analysis of
ruptured plaques. They analyzed cross sectional MR images of excised
arteries and ran a two dimensional stress analysis using ABACUS. Five
vulnerable plaques were used in this study, three that had not ruptured, and
two that had. The MR based geometries were obtained from MR
segmentation software based on the image characteristics of each material.
They also compared the MR based geometry with a histological based
geometry for each cross section. Figure 7 shows a comparison from their
study.

Figure 7. FEA GEOMETRIES BASED ON MR IMAGES Images of a specimen used for
FEA in the work of Li et al. (a) (b) (d) (e) MR images. (c) histological image. (d)
23
geometry used for FEA based on MR images.
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The final geometries contained three different plaque components: the artery
wall, lipid pool, and fibrous cap. The materials were given consistent
properties throughout the study, so that the results could emphasize the effect
of the geometry on plaque rupture. An Ogden strain energy formulation was
chosen for the material properties in their finite element analysis. The
purpose of this was to try to simulate the non-linear material properties of
arteries and atherosclerotic lesions. The results shown in their analysis can
be seen in Figure 8. The peak stress of the ruptured plaques are about 6.5
MPa, and 1.5 MPa to 3.5 MPa for the ruptured but vulnerable plaques.

Figure 8. MAXIMUM STRESSES OF VULNERABLE PLAQUES Results shown by Li et
al. of the peak stress after finite element analysis of 5 excised arteries. Specimins 1-3
23
were unruptured, and specimens 4 and 5 were ruptured.

This study showed similarities between the MR and histological based
geometries, and showed that MR imaging could be promising to the field
because it allows for computer aided geometries. This method could greatly
increase the accuracy and repeatability of geometry determination.

24
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MECHANICAL ANALYSIS USING OCT

Optical coherence tomography works in a similar manner as ultrasound, but it
uses light waves as its medium. OCT is a newer technology, and is
promising because of its high resolution (10 µm X 25 µm). The high
resolution is a result of technology because it requires a light source that can
emit a broad range of frequencies.

Alexandra H. Chau et al. did a study where they compared the analysis of
geometries obtained from OCT images with those obtained from histological
images. They used two types of lesions: one with a lipid pool and fibrous
plaque surrounding it, and one with fibrous plaque surrounding a calcium
deposit. The determined geometries (with lipid pools) from each imaging
method are shown in Figure 9 along with their stress and strain analysis.
Their analysis was on a two dimensional cross section of an excised artery.
Their analysis showed that OCT based geometries provide similar stress and
strain distributions, but the peak stresses could appear much lower than the
histological based geometries. They attributed this inconsistency to the fact
that the histological based image may have sharper edges and shoulders due
to processing.

26

Figure 9. ANALYSIS OF PLAQUE DEFORMATION Comparison of geometry
determination and finite element analysis done by Chau et al. The left side is an OCT
5
image set, and the right side is the corresponding histological image.
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CHAPTER THREE: THE IMPACT OF LIPID PERCENTAGE ON FIBROUS
CAP STABILITY

There is quite a bit of current research in the field of atherosclerosis. Some
researchers are doing physical experiments on excised arteries to determine
the mechanical properties of each component of a lesion. Others are creating
both two and three dimensional finite element analyses based on these
mechanical properties, and use geometries based on histological images of
excised arteries. Others still are attempting to use imaging techniques to
determine mechanical properties, and comparing the finite element analyses
of geometries based on imaging to those based on excised arteries.

No research yet has focused on providing a method of standardizing the finite
element analysis to draw correlations between different lesion compositions
and geometries and mechanical stability. Because each lesion is so different,
it would be extremely helpful to create an analysis system where any lesion,
regardless of its shape, size, or composition, could be analyzed quickly and
accurately for plaque stability.

This project uses finite element techniques to examine the stress
concentrations between different plaque compositions. The main focus is to
determine the change in plaque stability as the ratio of lipid content to fibrous
tissue content changes. A two dimensional finite element analysis was done,
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and the lipid and fibrous tissue content was varied linearly. Each two
dimensional drawing represented a cross section of a carotid artery, with a
five millimeter diameter. Since the purpose of this study was to look at the
effects of lipid vs. fibrous tissue content, each cross section represented a
single layered atheroma, with no presence of calcium.

MATERIALS AND METHODS

Each arterial cross section was analyzed using COMSOL Multiphysics two
dimensional stress-strain analysis. The artery was considered to be a closed
system, and every component of the artery was given its own material
properties. The lumen was not considered part of the system because
research showed that hemodynamic stresses are negligible.

.An example of a typical cross section geometry can be seen in Figure 10.
This shape was chosen due to a couple factors. The cross section was to be
asymmetrical in only one direction, in order to simplify the analysis and obtain
continuity of the results. A lesion shape was chosen based on typical lesion
shapes shown in studies. After a vague shape was chosen, it needed to be
represented mathematically. Many options exist to represent a typical lesion
shape; however the chosen shape had to be able to range from 10%-90%
lipid, and still be contained in the borders of the circular 5mm diameter artery.
Although larger lesions tend to distort the outer diameter of the artery, a
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circular shape was chosen throughout all cross sections to avoid any stress
concentration gradients due to the artery shape. The final shape of the
atheromatous core was made by the area between two offset circles. The
diameter of the superficial circle was twice the size of the inner circle. The
cap thickness was the distance between the lumen and inner edge of the
atheromatous core. The lumen and outer edge of the core were equidistant
from the artery wall, and the lesion was also centered in the other dimension.

The materials were given linear elasticity, and the elastic modulus, E, for each
is shown in Table 3. The Poisson’s ratio for all materials was 0.4999. These
values were kept constant throughout each analysis as a control variable, and
are the values used in work by Radj A. Baldewsing et al. The percent
stenosis was kept constant at 50%. This was a realistic number for lesions of
interest, without being so great as to cause extra shear stress on the lesion
due to hemodynamic flow. The percentage of the artery area that makes up
the plaque was determined from this stenosis. The lipid and plaque
percentages were calculated based on the entire lesion area. The lipid
percentage was ranged from 10% to 90%, and the cap thickness was varied
from 65µm to 250 µm. This is the range of cap thickness that is typically
considered vulnerable. The values chosen for thickness were 65µm, 100µm,
200µm, and 250µm. These values were chosen to represent the smallest
realistic cap thickness and the largest vulnerable cap thickness. The two
values in between were chosen as references for values in between. The
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applied pressure on all analyses was 16 kPa, which is equivalent to about
120 mmHg. This pressure was applied to the lumen wall, and was chosen
because it represents a systolic blood pressure on the higher end of the
normal range for adults.

Table 4. Elastic Modulus of Artery and Lesion Components
Material

Artery Wall

Lipid Pool

Fibrous Tissue

Elastic Modulus, E

16.8 kPa

50kPa

1250kPa

The shape and material properties of the arterial wall were kept constant
throughout all cross sections. The shape of the artery wall was chosen to be
circular, and the lesion was chosen to be off center. This is in part due to the
fact that most lesions are typically a bit eccentric, and are located on one side
of the artery. The distance between the lumen and arterial wall, and the lipid
and arterial wall were chosen to be equidistant, to avoid any unsymmetrical
stress concentrations due to a thin artery wall. Since three separate tunics
make up the arterial wall, they were averaged into one elastic modulus and
thickness.
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RESULTS

Figure10 shows an example of a typical analysis. Figures 11-14 show plots
of the lipid percentage vs. peak stress on each analysis based on the fibrous
cap thickness. Each individual analysis can be seen in Appendix A. The
results show a linear increase in peak stress as the lipid pool grows. The R2
values are consistently close to 1.0, ranging from 0.927 to 0.976. The peak
stresses for forty to fifty percent range from 2E6 to 6E6 depending on the cap
thickness. This is higher than the finite element analyses done on geometries
based on excised arteries, but this is due to the ideal nature of the
geometries. This limitation and the possibilities of overcoming it are
explained later in this project.
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Figure 10. FEA EXAMPLE USING COMSOL Example of a finite element analysis using
COMSOL Multiphysics.

33

R2 = 0.9743

65 µm Fibrous cap
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Figure 11. FEA RESULTS WITH A 65 µm FIBROUS CAP Results of a finite element
analysis of cross sections ranging from 10% lipid to 90% lipid with a 65 µm fibrous cap
thickness.

R2 = 0.9339
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Figure 12. FEA RESULTS WITH A 100 µm FIBROUS CAP Results of a finite element
analysis of cross sections ranging from 10% lipid to 90% lipid with a 100 µm fibrous
cap thickness.
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R2 = 0.9599
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Figure 13. FEA RESULTS WITH A 200 µm FIBROUS CAP Results of a finite element
analysis of cross sections ranging from 10% lipid to 90% lipid with a 200 µm fibrous
cap thickness.

R2 = 0.6589
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Figure 14. FEA RESULTS WITH A 250 µm FIBROUS CAP Results of a finite element
analysis of cross sections ranging from 10% lipid to 90% lipid with a 250 µm fibrous
cap thickness.
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DISCUSSION

The peak stresses of this analysis are noticeably higher than typical finite
element analyses done using histological geometries from cross sections of
excised arteries. This could possibly be due to the imperfect nature of
physiologic geometries.

Excised arteries typically have peak stresses located at the shoulders of the
plaque, where curvature of the fibrous cap can be extremely sharp. Also, the
composition of both the lipid pool and the fibrous part of the plaque may not
be completely uniform throughout; whereas the idealized model is uniform
throughout. The peak stresses can also be noticeably different from those
obtained by experimentation of excised arteries due to all of the above
reasons. Another possibility for discrepancies between excised arteries and
ideal models is the possibility of physical imperfections such as fissures.
Natural lesions may also contain multiple atheromas and the presence of
other materials such as calcium. These factors would indeed affect the
mechanical stability of the lesion, but are not portrayed in this project.

Another physiologic feature of artery walls that is not portrayed in the finite
element model is the ability of the wall to stretch to a wider diameter during
pulsatile flow. In the COMSOL analysis, the arteries are restricted to their
5mm diameter, so the wall (and lesion) can be subjected to a higher
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maximum stress than in physiologic conditions. In the physiologic conditions,
the minimum stress of the artery should be zero. However, in the finite
element analysis, there is a minimum stress that is greater than zero. The
difference between the peak stress and minimum stress represents the actual
stress on the artery wall if the outer diameter was not constrained. The “peak
stress” in the results section depicts this value.

It is important to note that the geometries chosen for this analysis are rather
simple, and are not completely indicative of real lesion geometries. For
instance, in real lesions, the lipid pools are not shapes made up of offset
circles with a perfectly uniform fibrous cap. Instead, natural plaque buildup
forms with sharp edges, especially near the shoulders of the lesion. The cap
thickness can also vary within the lesion. This “roughness” creates many
different stress concentrations throughout the fibrous cap where it could
fissure or rupture at stresses well below those of the smooth sections. Since
the geometries of this project must use a method that is repeatable and
consistent from one lipid pool size to the next, mathematically reproducible
shapes are used. The lipid pools of this project have smooth edges, and the
fibrous cap is a consistent thickness throughout the lesion. These smooth
shapes obviously show stress similar to the smooth sections of real lesions,
rather than the rough edges. With further research, the natural stress
concentrations could be incorporated into the finite element methods to show
more realistic values. However, accounting for these differences between
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actual and ideal lesions is not easy, and requires a great deal of research and
experimentation.

A possible fix would be to compare the finite element analysis based on the
geometries of actual lesions with those of the standardized geometries. This
difference could be plotted for each lipid volume percentage, to see if a
correlation is present between the two graphs. A finite element analysis could
be done on each histological cross section based on the natural shape of the
lesion. Values for peak stress of lesions with similar material volumes (i.e.
40% lipid and a minimum fibrous cap of 65 µm) could then be averaged to
represent a large population. This would help to achieve standardization.
Also, the excised lesions would have to be examined to ensure the correct
physical properties, such as cap thickness, material concentrations, and the
elastic modulus of those materials. Although it is very important to mimic
lesion shape as closely as possible, this work would take a large amount of
time and resources, so it is beyond the scope of this project.

Another limitation of this project is the simplification of the material properties
of plaque. Realistically, each component of plaque probably has at least
some non-linear elasticity. However, there are many studies that show how
the non-linear material properties may be negligible, so this study does the
same. The use of more physiologic material properties in finite element
analyses is a large area of research that proves to be quite in depth in the
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areas of mathematics and thermodynamics. Thus, it is considered beyond
the scope of this project.

FUTURE IMPLICATIONS

Although this project does not provide a direct solution to completely
understanding plaque stability, it can be used to understand at least a part of
it. This project can be part of research to create a standardized model for
plaque stability. A standardized model could be an algorithm that takes input
parameters specific to a certain lesion and outputs a finite element analysis.
The use of imaging modalities certainly would play a big role, and may
facilitate lesion analysis without even minimally invasive surgery.

A foreseeable use of a standardized model in combination with medical
imaging is the field of diagnostics. Currently, many patients with
atherosclerosis go undiagnosed until a major clinical event. Others may know
they have some sort of plaque buildup or risk factors, but may not know
exactly how the disease will play out. A standard diagnostic tool that predicts
future behavior and current risk level would be a great tool for physicians and
could prevent many injuries and even deaths due to atherosclerosis. Even
though a simple algorithm may not be achieved due to the complexity of the
disease, a database that contains possible implications could be very useful
in the prevention of disease progression. This database could be a computer
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program in which quantifiable parameters are entered and likely progressions
and risk implications are outputted to the physician. A chart could be used to
identify risk based on non-quantifiable features, such as shape or
nonsymmetrical lesions. These methods could be of great use in the medical
field, and help to achieve more efficient patient care.

This sort of model would have a wide variety of applications in the clinical and
industrial field. For instance, non-invasive lesion analysis could allow
cardiologists to determine plaque stability quicker and more accurately,
resulting in safer and more efficient patient care. In industry, a finite element
model could be used for device testing before a physical artery model is even
made. The use of a computational model could provide easy reproducibility
of these tests, thus allowing more analyses to be run. If a large number of
tests could be run in a short time, then a wide variety of lesions could be
tested. This is especially important because lesions vary so greatly in
composition from person to person, and even between lesions themselves.

Eventually, as all the limitations of this project are researched and overcome,
a standardized model will come together and greatly improve the
understanding of atherosclerosis.
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APPENDIX

This appendix displays the results of all COMSOL simulations used in this
project.
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The following are the finite element analyses for a fibrous cap thickness of
200 µm with a lipid concentration ranging from 10% to 90% lipid.

Fibrous Cap = 65µm Atheroma = 10%

42

Fibrous Cap = 65µm Atheroma = 20%

43

Fibrous Cap = 65µm Atheroma = 30%

44

Fibrous Cap = 65µm Atheroma = 40%

45

Fibrous Cap = 65µm Atheroma = 50%

46

Fibrous Cap = 65µm Atheroma = 60%

47

Fibrous Cap = 65µm Atheroma = 70%

48

Fibrous Cap = 65µm Atheroma = 80%

49

Fibrous Cap = 65µm Atheroma = 90%
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The following are the finite element analyses for a fibrous cap thickness of
200 µm with a lipid concentration ranging from 10% to 90% lipid.

Fibrous Cap = 100µm Atheroma = 10%

51

Fibrous Cap = 100µm Atheroma = 20%

52

Fibrous Cap = 100µm Atheroma = 30%

53

Fibrous Cap = 100µm Atheroma = 40%

54

Fibrous Cap = 100µm Atheroma = 50%

55

Fibrous Cap = 100µm Atheroma = 60%

56

Fibrous Cap = 100µm Atheroma = 70%

57

Fibrous Cap = 100µm Atheroma = 80%

58

Fibrous Cap = 100µm Atheroma = 90%
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The following are the finite element analyses for a fibrous cap thickness of
200 µm with a lipid concentration ranging from 10% to 90% lipid.

Fibrous Cap = 200µm Atheroma = 10%

60

Fibrous Cap = 200µm Atheroma = 20%

61

Fibrous Cap = 200µm Atheroma = 30%

62

Fibrous Cap = 200µm Atheroma = 40%

63

Fibrous Cap = 200µm Atheroma = 50%

64

Fibrous Cap = 200µm Atheroma = 60%

65

Fibrous Cap = 200µm Atheroma = 70%

66

Fibrous Cap = 200µm Atheroma = 80%

67

Fibrous Cap = 200µm Atheroma = 90%
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The following are the finite element analyses for a fibrous cap thickness of
250 µm with a lipid concentration ranging from 10% to 90% lipid.

Fibrous Cap = 200µm Atheroma = 10%

69

Fibrous Cap = 200µm Atheroma = 20%

70

Fibrous Cap = 200µm Atheroma = 30%

71

Fibrous Cap = 200µm Atheroma = 40%

72

Fibrous Cap = 200µm Atheroma = 50%

73

Fibrous Cap = 200µm Atheroma = 60%

74

Fibrous Cap = 200µm Atheroma = 70%

75

Fibrous Cap = 200µm Atheroma = 80%

76

Fibrous Cap = 200µm Atheroma = 90%
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